Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abcellute was a biotechnology company specializing in the development of innovative cell preservation and transportation technologies for the life sciences industry. The company's core platform enabled the storage and shipment of mammalian cells at ambient temperatures for extended periods, effectively bypassing the need for cryopreservation or complex cold-chain logistics. By utilizing a proprietary encapsulation method, the technology maintained cell viability and biological function during transit, facilitating the global distribution of cell-based therapies and research materials. Spun out from the University of Nottingham, Abcellute targeted critical logistical challenges in regenerative medicine, drug discovery, and clinical diagnostics. Although the company is no longer active, its platform represented a significant advancement in simplifying the supply chain for live biological materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abcellute.